PROX1 and thyroid gland carcinoma: Choi D. et al., 2016 described that PTC specimens show a consistent downregulation of PROX1 by more than 2-fold (p < 1 × 10−4) compared to normal thyroid tissues, which was confirmed by our simulation (with GEPIA database) using another set of thyroid cancer gene profiling studies (Figure 3).